The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2015

Filed:

Nov. 05, 2008
Applicants:

Tammy R. Dugas, Bossier City, LA (US);

Alok Khandelwal, Shreveport, LA (US);

James John Kleinedler, Iii, Shreveport, LA (US);

John Devlin Foley, Lino Lakes, MN (US);

Inventors:

Tammy R. Dugas, Bossier City, LA (US);

Alok Khandelwal, Shreveport, LA (US);

James John Kleinedler, III, Shreveport, LA (US);

John Devlin Foley, Lino Lakes, MN (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 2/82 (2013.01); A61L 31/16 (2006.01); A61L 31/10 (2006.01); A61L 31/14 (2006.01); A61F 2/915 (2013.01);
U.S. Cl.
CPC ...
A61L 31/16 (2013.01); A61L 31/10 (2013.01); A61L 31/146 (2013.01); A61F 2/915 (2013.01); A61F 2002/91508 (2013.01); A61F 2002/91558 (2013.01); A61F 2250/0067 (2013.01); A61L 2300/608 (2013.01); A61L 2300/416 (2013.01); A61L 2300/422 (2013.01);
Abstract

The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.


Find Patent Forward Citations

Loading…